| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ribosome binding | 2.64e-05 | 120 | 198 | 8 | GO:0043022 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | SPATA7 KNTC1 TPR IFT140 ERBB4 TTC21A ZMYND8 SRP9 RYR2 PYHIN1 SCML2 NF1 NOMO2 FERMT2 PHIP KPNA1 NUP88 NUP98 CCT7 SNUPN KIF20B NOMO1 WDR19 RANBP17 PPP1R10 SETD2 VPS13D SLF2 MTOR CTNNA1 GGA1 NOMO3 DNAH11 | 2.20e-09 | 1091 | 193 | 33 | GO:0033365 |
| GeneOntologyBiologicalProcess | protein localization to nucleus | TPR PYHIN1 NF1 FERMT2 PHIP KPNA1 NUP88 NUP98 CCT7 SNUPN RANBP17 PPP1R10 MTOR CTNNA1 | 8.48e-06 | 362 | 193 | 14 | GO:0034504 |
| GeneOntologyBiologicalProcess | transcription elongation by RNA polymerase II | 2.64e-05 | 127 | 193 | 8 | GO:0006368 | |
| GeneOntologyBiologicalProcess | RNA export from nucleus | 3.33e-05 | 96 | 193 | 7 | GO:0006405 | |
| GeneOntologyBiologicalProcess | RNA localization | 3.95e-05 | 217 | 193 | 10 | GO:0006403 | |
| GeneOntologyBiologicalProcess | RNA transport | 4.13e-05 | 175 | 193 | 9 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 4.13e-05 | 175 | 193 | 9 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 4.72e-05 | 178 | 193 | 9 | GO:0051236 | |
| GeneOntologyBiologicalProcess | nuclear transport | TPR NF1 SUPT6H NXF2 PHIP KPNA1 THOC1 NUP88 NUP98 SNUPN RANBP17 PPP1R10 SETD2 | 6.02e-05 | 378 | 193 | 13 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | TPR NF1 SUPT6H NXF2 PHIP KPNA1 THOC1 NUP88 NUP98 SNUPN RANBP17 PPP1R10 SETD2 | 6.02e-05 | 378 | 193 | 13 | GO:0006913 |
| GeneOntologyBiologicalProcess | DNA-templated transcription elongation | 6.46e-05 | 144 | 193 | 8 | GO:0006354 | |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 6.50e-05 | 9 | 193 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | mRNA export from nucleus | 6.78e-05 | 74 | 193 | 6 | GO:0006406 | |
| GeneOntologyBiologicalProcess | mRNA transport | 6.79e-05 | 145 | 193 | 8 | GO:0051028 | |
| GeneOntologyBiologicalProcess | protein localization to cilium | 8.48e-05 | 77 | 193 | 6 | GO:0061512 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 9.53e-05 | 195 | 193 | 9 | GO:0006606 | |
| GeneOntologyBiologicalProcess | import into nucleus | 1.20e-04 | 201 | 193 | 9 | GO:0051170 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | TPR SUPT6H NXF2 THOC1 SLC35B3 NUP88 NUP98 SNUPN RANBP17 SETD2 | 1.24e-04 | 249 | 193 | 10 | GO:0015931 |
| GeneOntologyBiologicalProcess | regulation of mRNA export from nucleus | 1.26e-04 | 11 | 193 | 3 | GO:0010793 | |
| GeneOntologyBiologicalProcess | regulation of wound healing, spreading of epidermal cells | 1.26e-04 | 11 | 193 | 3 | GO:1903689 | |
| GeneOntologyBiologicalProcess | regulation of ribonucleoprotein complex localization | 2.15e-04 | 13 | 193 | 3 | GO:2000197 | |
| GeneOntologyBiologicalProcess | growth | ERBB4 UBTFL1 IMPACT CLASP2 EXTL3 SOCS6 DYSF PYHIN1 SGK3 RTF1 SEMA3A RMI1 TMTC3 PHIP DNM2 KPNA1 AKAP6 AGR2 SPAG9 MTOR CCNB2 DUSP10 PRKDC PRKG1 KDM1A | 2.28e-04 | 1235 | 193 | 25 | GO:0040007 |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex localization | 2.72e-04 | 14 | 193 | 3 | GO:0071166 | |
| GeneOntologyCellularComponent | intraciliary transport particle A | 4.53e-05 | 8 | 198 | 3 | GO:0030991 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 6.74e-05 | 9 | 198 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.53e-04 | 161 | 198 | 8 | GO:0005875 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 2.82e-04 | 14 | 198 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | nuclear pore | 4.02e-04 | 101 | 198 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | HCN channel complex | 5.29e-04 | 4 | 198 | 2 | GO:0098855 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 5.47e-04 | 107 | 198 | 6 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 5.47e-04 | 107 | 198 | 6 | GO:0001725 | |
| GeneOntologyCellularComponent | actomyosin | 8.76e-04 | 117 | 198 | 6 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 9.16e-04 | 118 | 198 | 6 | GO:0032432 | |
| GeneOntologyCellularComponent | I band | 1.05e-03 | 166 | 198 | 7 | GO:0031674 | |
| Domain | DUF2012 | 4.45e-06 | 4 | 195 | 3 | PF09430 | |
| Domain | DUF2012 | 4.45e-06 | 4 | 195 | 3 | IPR019008 | |
| Domain | Carb-bd-like_fold | 6.04e-05 | 8 | 195 | 3 | IPR013784 | |
| Domain | Peptidase_M16_M | 1.08e-04 | 2 | 195 | 2 | PF16187 | |
| Domain | Peptidase_M16_M | 1.08e-04 | 2 | 195 | 2 | IPR032632 | |
| Domain | ARM-like | CEP104 PSMD1 CLASP2 NF1 KPNA1 DOCK8 TOGARAM2 RANBP17 KATNBL1 MTOR PRKDC | 1.31e-04 | 270 | 195 | 11 | IPR011989 |
| Domain | ARM-type_fold | CEP104 DOCK11 PSMD1 CLASP2 FOCAD NF1 KPNA1 DOCK8 TOGARAM2 RANBP17 MTOR PRKDC | 2.42e-04 | 339 | 195 | 12 | IPR016024 |
| Domain | CarboxyPept_regulatory_dom | 2.97e-04 | 13 | 195 | 3 | IPR014766 | |
| Domain | - | 2.97e-04 | 13 | 195 | 3 | 2.60.40.1120 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.75e-04 | 14 | 195 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.75e-04 | 14 | 195 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.75e-04 | 14 | 195 | 3 | IPR013602 | |
| Domain | DHC_N2 | 3.75e-04 | 14 | 195 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 3.75e-04 | 14 | 195 | 3 | IPR011704 | |
| Domain | MT | 3.75e-04 | 14 | 195 | 3 | PF12777 | |
| Domain | AAA_8 | 3.75e-04 | 14 | 195 | 3 | PF12780 | |
| Domain | AAA_5 | 3.75e-04 | 14 | 195 | 3 | PF07728 | |
| Domain | DHC_fam | 4.65e-04 | 15 | 195 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 4.65e-04 | 15 | 195 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 4.65e-04 | 15 | 195 | 3 | IPR004273 | |
| Domain | - | 5.57e-04 | 222 | 195 | 9 | 1.25.10.10 | |
| Domain | cNMP-bd_CS | 5.68e-04 | 16 | 195 | 3 | IPR018488 | |
| Domain | Ion_trans_N | 6.42e-04 | 4 | 195 | 2 | IPR013621 | |
| Domain | CLASP_N | 6.42e-04 | 4 | 195 | 2 | PF12348 | |
| Domain | CLASP_N_dom | 6.42e-04 | 4 | 195 | 2 | IPR024395 | |
| Domain | Ion_trans_N | 6.42e-04 | 4 | 195 | 2 | PF08412 | |
| Domain | Bromodomain | 6.44e-04 | 38 | 195 | 4 | PF00439 | |
| Domain | CarboxyPept-like_regulatory | 6.84e-04 | 17 | 195 | 3 | IPR008969 | |
| Domain | RasGAP_dom | 8.15e-04 | 18 | 195 | 3 | IPR001936 | |
| Domain | BROMODOMAIN_2 | 8.63e-04 | 41 | 195 | 4 | PS50014 | |
| Domain | Bromodomain | 9.46e-04 | 42 | 195 | 4 | IPR001487 | |
| Domain | BROMO | 9.46e-04 | 42 | 195 | 4 | SM00297 | |
| Domain | - | 9.46e-04 | 42 | 195 | 4 | 1.20.920.10 | |
| Domain | GAE | 1.06e-03 | 5 | 195 | 2 | PS50180 | |
| Domain | FATC | 1.06e-03 | 5 | 195 | 2 | PF02260 | |
| Domain | - | 1.58e-03 | 6 | 195 | 2 | 2.60.40.1230 | |
| Domain | GAT_dom | 1.58e-03 | 6 | 195 | 2 | IPR004152 | |
| Domain | DUF3398 | 1.58e-03 | 6 | 195 | 2 | PF11878 | |
| Domain | - | 1.58e-03 | 6 | 195 | 2 | 1.20.58.160 | |
| Domain | Clathrin_g-adaptin_app | 1.58e-03 | 6 | 195 | 2 | IPR008153 | |
| Domain | GAT | 1.58e-03 | 6 | 195 | 2 | PS50909 | |
| Domain | FAT | 1.58e-03 | 6 | 195 | 2 | PS51189 | |
| Domain | FATC | 1.58e-03 | 6 | 195 | 2 | PS51190 | |
| Domain | FAT | 1.58e-03 | 6 | 195 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 1.58e-03 | 6 | 195 | 2 | IPR003151 | |
| Domain | FATC_dom | 1.58e-03 | 6 | 195 | 2 | IPR003152 | |
| Domain | DOCK_C/D_N | 1.58e-03 | 6 | 195 | 2 | IPR021816 | |
| Domain | PIK_FAT | 1.58e-03 | 6 | 195 | 2 | IPR014009 | |
| Domain | GAT | 1.58e-03 | 6 | 195 | 2 | PF03127 | |
| Domain | FATC | 1.58e-03 | 6 | 195 | 2 | SM01343 | |
| Domain | TPR_REGION | 1.76e-03 | 165 | 195 | 7 | PS50293 | |
| Domain | TPR | 1.76e-03 | 165 | 195 | 7 | PS50005 | |
| Pathway | REACTOME_HIV_LIFE_CYCLE | 3.55e-06 | 149 | 147 | 10 | M4076 | |
| Pathway | REACTOME_MRNA_CAPPING | 1.12e-05 | 29 | 147 | 5 | M745 | |
| Pathway | REACTOME_MRNA_CAPPING | 1.12e-05 | 29 | 147 | 5 | MM15409 | |
| Pathway | REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX | 3.01e-05 | 58 | 147 | 6 | M805 | |
| Pathway | REACTOME_HIV_INFECTION | TPR ERCC3 ELOA2 RNMT RNGTT PSMD1 KPNA1 POLR2A NUP88 NUP98 GTF2F1 | 3.02e-05 | 231 | 147 | 11 | M12469 |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 3.35e-05 | 36 | 147 | 5 | M27245 | |
| Pathway | REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME | 8.79e-05 | 70 | 147 | 6 | M27008 | |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 9.01e-05 | 44 | 147 | 5 | M109 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES | 1.24e-04 | 47 | 147 | 5 | MM15328 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS | 1.98e-04 | 81 | 147 | 6 | M865 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 2.21e-04 | 53 | 147 | 5 | M27212 | |
| Pathway | REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX | 3.67e-04 | 59 | 147 | 5 | MM14504 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | TPR RNMT SPTAN1 PSMD1 STXBP2 NOMO2 FERMT2 DNM2 DHX58 HSPA4L CCT7 OSGEP NOMO1 PRKDC NOMO3 NCKAP1L | 1.94e-10 | 344 | 200 | 16 | 30333137 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | DOCK11 GPN1 ZMYND8 CLASP2 AK9 DYSF RTF1 KIF2A HSPA4L POLR2A TOGARAM2 KMO PPP1R10 VPS13D ERLIN2 XIRP2 CTNNA1 KDM1A | 7.76e-10 | 497 | 200 | 18 | 36774506 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ERCC3 RNGTT DOCK11 RNF40 NF1 SUPT6H KIF2A KPNA1 HSPA4L POLR2A NUP88 NUP98 CCT7 SETD2 FUS KDM1A | 6.65e-09 | 440 | 200 | 16 | 34244565 |
| Pubmed | TPR SPTAN1 PSMD1 NF1 SUPT6H PHIP DNM2 NAA15 PUF60 POLR2A NUP88 NUP98 SPAG9 KRR1 MTOR CTNNA1 PRKDC FUS KDM1A | 9.24e-09 | 653 | 200 | 19 | 22586326 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DUSP12 RNGTT PSMD1 TMTC3 UPP1 GID8 KPNA1 NAA15 NRDC HSPA4L NUP88 NUP98 CCT7 SPAG9 IDE OSGEP NOMO1 ERLIN2 MTOR DUSP10 CTNNA1 PRKDC KDM1A | 1.20e-08 | 974 | 200 | 23 | 28675297 |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | RNGTT GPN1 SRP9 GPATCH4 CLASP2 SUPT6H KPNA1 LIMA1 HSPA4L PUF60 POLR2A NUP98 SPAG9 KRR1 NOMO1 MTOR CDK13 KDM1A NOMO3 | 1.39e-08 | 670 | 200 | 19 | 22990118 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KNTC1 TPR SPTAN1 PSMD1 GPATCH4 CLASP2 OLA1 NF1 SUPT6H KIF2A PHIP THOC1 NRDC DNAH10 HSPA4L PUF60 POLR2A NUP88 NUP98 CCT7 IDE KRR1 NOMO1 ERLIN2 MTOR PRKDC FUS KDM1A | 1.49e-08 | 1425 | 200 | 28 | 30948266 |
| Pubmed | TPR ATP6V1E1 NDUFS7 ERCC3 SPTAN1 SRP9 PSMD1 GPATCH4 CLASP2 OLA1 KIF2A DNM2 THOC1 LIMA1 HSPA4L PUF60 POLR2A AGR2 NUP98 CCT7 YES1 ERLIN2 CTNNA1 PRKDC FUS KDM1A | 1.58e-08 | 1247 | 200 | 26 | 27684187 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | KNTC1 ATP6V1E1 SPTAN1 GPN1 SRP9 PSMD1 OLA1 RTF1 GID8 FERMT2 KPNA1 NIBAN1 NAA15 NRDC HSPA4L PUF60 POLR2A NUP88 NUP98 CCT7 SPAG9 IDE OSGEP GTF2F1 MTOR CTNNA1 PRKDC FUS | 2.31e-08 | 1455 | 200 | 28 | 22863883 |
| Pubmed | SPTAN1 PSMD1 CLASP2 SUPT6H KIF2A DNM2 NAA15 HSPA4L PUF60 POLR2A NUP98 CCT7 SPAG9 NOMO1 MTOR PRKDC FUS KDM1A | 3.68e-08 | 638 | 200 | 18 | 33239621 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | TPR RNMT TMOD2 OLA1 GDAP1L1 KIF2A PPIP5K2 FERMT2 PHIP KPNA1 HSPA4L POLR2A YES1 CDK13 CTNNA1 KDM1A | 3.73e-08 | 498 | 200 | 16 | 36634849 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TPR SPTAN1 GPN1 SRP9 PSMD1 GPATCH4 CLASP2 RNF40 OLA1 RTF1 SUPT6H UPP1 GID8 KIF2A KPNA1 NAA15 NRDC HSPA4L PUF60 POLR2A CCT7 KRR1 GTF2F1 CDK13 CTNNA1 PRKDC FUS | 5.02e-08 | 1415 | 200 | 27 | 28515276 |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | SPTAN1 PHIP DNM2 HSPA4L POLR2A CCT7 PPP1R10 CTNNA1 PRKDC FUS KDM1A | 6.58e-08 | 219 | 200 | 11 | 31353912 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TPR PSMD1 OLA1 PLXNB2 NF1 STXBP2 SUPT6H KIF2A PHIP THOC1 NIBAN1 LIMA1 PUF60 POLR2A NUP98 CCT7 YES1 PPP1R10 CTNNA1 PRKDC FUS KDM1A | 1.31e-07 | 1024 | 200 | 22 | 24711643 |
| Pubmed | 1.87e-07 | 3 | 200 | 3 | 36011023 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 1.87e-07 | 3 | 200 | 3 | 25576386 | |
| Pubmed | Recombinant human mRNA cap methyltransferase binds capping enzyme/RNA polymerase IIo complexes. | 1.87e-07 | 3 | 200 | 3 | 9705270 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | SPATA7 IFT140 RNGTT TTC21A CLASP2 OLA1 NF1 GID8 PPIP5K2 FERMT2 DNM2 LIMA1 NUP88 SPAG9 OSGEP NOMO1 WDR19 PPP1R10 ERLIN2 HAUS1 MTOR CTNNA1 GGA1 PCDH9 KDM1A | 1.92e-07 | 1321 | 200 | 25 | 27173435 |
| Pubmed | Isolation and characterization of a human cDNA for mRNA 5'-capping enzyme. | 2.89e-07 | 25 | 200 | 5 | 9512541 | |
| Pubmed | 2.89e-07 | 25 | 200 | 5 | 9790902 | ||
| Pubmed | TPR ERCC3 MIS18BP1 RNMT ZMYND8 RNF40 OLA1 RTF1 SUPT6H UPP1 THOC1 PUF60 POLR2A NUP98 CCT7 PPP1R10 SETD2 GTF2F1 CDK13 PRKDC KDM1A | 4.68e-07 | 1014 | 200 | 21 | 32416067 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | KNTC1 TPR ATP6V1E1 SPTAN1 SRP9 RNF40 SUPT6H DNM2 KPNA1 DNAH3 LIMA1 NAA15 HSPA4L CCT7 IDE HARS2 GTF2F1 ERLIN2 PRKDC | 5.21e-07 | 847 | 200 | 19 | 35235311 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR SPTAN1 ZMYND8 PSMD1 SCML2 NF1 DNM2 THOC1 LIMA1 ITSN1 POLR2A NUP98 SPAG9 USP16 SETD2 CDK13 CTNNA1 PRKDC | 6.30e-07 | 774 | 200 | 18 | 15302935 |
| Pubmed | 7.46e-07 | 4 | 200 | 3 | 19141475 | ||
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 7.46e-07 | 4 | 200 | 3 | 31833031 | |
| Pubmed | 7.46e-07 | 4 | 200 | 3 | 9267806 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | KNTC1 TPR GPATCH4 CLASP2 RMI1 KPNA1 NAA15 POLR2A NUP88 NUP98 CCT7 SPAG9 IDE YES1 PPP1R10 GTF2F1 HAUS1 CCNB2 CTNNA1 PRKDC FUS KDM1A | 9.90e-07 | 1155 | 200 | 22 | 20360068 |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | TPR ZMYND8 PHIP KPNA1 PUF60 POLR2A NUP98 CCT7 ERLIN2 PRKDC KDM1A | 1.04e-06 | 289 | 200 | 11 | 23752268 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TPR SPTAN1 PSMD1 OLA1 NF1 DNM2 KPNA1 DOCK8 PUF60 CCT7 SNUPN CTNNA1 PRKDC FUS KDM1A | 1.62e-06 | 582 | 200 | 15 | 20467437 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZMYND8 SRP9 GPATCH4 RNF40 RMI1 SCML2 TMTC3 SUPT6H THOC1 BAZ2B POLR2A NUP88 NUP98 PPP1R10 SETD2 FADS1 SLF2 CCNB2 CDK13 PRKDC FUS KDM1A SAMD4A | 1.78e-06 | 1294 | 200 | 23 | 30804502 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | KNTC1 MIS18BP1 RNGTT RNF40 RMI1 NOMO2 SUPT6H GID8 ITSN1 KIF20B SETD2 GTF2F1 SLF2 CCNB2 KDM1A | 1.83e-06 | 588 | 200 | 15 | 38580884 |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | DUSP12 IFT140 ATP6V1E1 SPTAN1 ZMYND8 PLXNB2 FOCAD RMI1 NOMO2 RPS6KA6 DNM2 ITSN1 CCT7 SPAG9 SNUPN OSGEP KATNBL1 MTOR DUSP10 CTNNA1 FAM219A | 2.40e-06 | 1124 | 200 | 21 | 21900206 |
| Pubmed | CEP104 KNTC1 MYH7 ELOA2 SPTAN1 SRP9 PSMD1 TEX35 RYR2 STXBP2 PPIP5K2 TOP1MT LIMA1 RARRES1 HSPA4L ITSN1 NUP98 INSYN2A ERLIN2 CDK13 DGKK PRKDC FUS PHTF1 | 3.24e-06 | 1442 | 200 | 24 | 35575683 | |
| Pubmed | TPR DOCK11 SRP9 PSMD1 FERMT2 CCT7 HARS2 CDK13 CTNNA1 PRKDC FUS KDM1A | 3.89e-06 | 399 | 200 | 12 | 37536630 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | DOCK11 TEX2 SPTAN1 CLASP2 RNF40 NF1 SUPT6H PHIP NAA15 HSPA4L POLR2A CCT7 ACAD10 | 4.27e-06 | 475 | 200 | 13 | 31040226 |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | ERCC3 RNGTT GPATCH4 RMI1 NF1 KPNA1 THOC1 DNAH3 LIMA1 KIF20B CDK13 FUS | 5.13e-06 | 410 | 200 | 12 | 26949251 |
| Pubmed | SPTAN1 ZMYND8 PSMD1 RNF40 EXTL3 FOCAD GDAP1L1 NOMO2 VPS35L DNM2 KPNA1 AKAP6 HCN1 ITSN1 ADNP2 CCT7 IDS USP16 WDR19 SLF2 CTNNA1 PRKDC | 5.51e-06 | 1285 | 200 | 22 | 35914814 | |
| Pubmed | NDUFS7 ERCC3 RNGTT ZMYND8 SRP9 GPATCH4 CLASP2 OLA1 SCML2 SUPT6H KIF2A KPNA1 POLR2A CCT7 KRR1 YES1 KIF20B NOMO1 PPP1R10 HARS2 SETD2 GTF2F1 CDK13 KDM1A | 6.10e-06 | 1497 | 200 | 24 | 31527615 | |
| Pubmed | KNTC1 RNGTT NEK6 ZMYND8 SRP9 OLA1 TRIM24 KIF2A DNM2 NAA15 DOCK8 BAZ2B PUF60 TOGARAM2 CCT7 GTF2F1 CDK13 PRKDC FUS KDM1A | 6.56e-06 | 1103 | 200 | 20 | 34189442 | |
| Pubmed | TPR ATP6V1E1 ERCC3 SPTAN1 SRP9 KIF2A KPNA1 THOC1 LIMA1 NUP88 NUP98 YES1 ERLIN2 PRKDC FUS | 7.37e-06 | 660 | 200 | 15 | 32780723 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR ZMYND8 GPATCH4 SCML2 FERMT2 DNM2 LIMA1 NAA15 PUF60 POLR2A NUP88 NUP98 CCT7 SPAG9 USP16 PPP1R10 SETD2 PRKDC | 8.60e-06 | 934 | 200 | 18 | 33916271 |
| Pubmed | ZMYND8 PSMD1 SVEP1 RYR2 DNM2 KPNA1 DOCK8 ITSN1 YES1 NOMO1 PPP1R10 CDK13 GGA1 NOMO3 | 9.43e-06 | 591 | 200 | 14 | 15231748 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | GGA2 MIS18BP1 GPN1 STXBP2 NOMO2 PPIP5K2 FERMT2 ITSN1 NUP88 CCT7 OSGEP YES1 CARD8 HAUS1 CCNB2 FUS GGA1 | 1.00e-05 | 853 | 200 | 17 | 28718761 |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 1.03e-05 | 8 | 200 | 3 | 15257293 | |
| Pubmed | A radial axis defined by semaphorin-to-neuropilin signaling controls pancreatic islet morphogenesis. | 1.03e-05 | 24 | 200 | 4 | 28893946 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TPR ZMYND8 GPATCH4 TRIM24 SCML2 PHIP THOC1 BAZ2B PUF60 POLR2A NUP98 KRR1 KIF20B PPP1R10 SETD2 SLF2 PRKDC FUS | 1.14e-05 | 954 | 200 | 18 | 36373674 |
| Pubmed | 1.53e-05 | 9 | 200 | 3 | 7926747 | ||
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 1.53e-05 | 9 | 200 | 3 | 36261522 | |
| Pubmed | Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. | 1.59e-05 | 92 | 200 | 6 | 10493829 | |
| Pubmed | TPR ERCC3 SPTAN1 GPN1 SUPT6H DNM2 KPNA1 PUF60 POLR2A GTF2F1 KDM1A | 1.80e-05 | 390 | 200 | 11 | 17643375 | |
| Pubmed | TPR AOC1 RNMT TEX2 GNG13 PSMD1 CLASP2 SCML2 VPS35L KIF2A FERMT2 PLXNB1 DNM2 AKAP6 NRDC ITSN1 KRR1 HAUS1 NCKAP1L | 1.80e-05 | 1084 | 200 | 19 | 11544199 | |
| Pubmed | TPR ZMYND8 SRP9 PSMD1 OLA1 GID8 KIF2A KPNA1 PUF60 CCT7 KIF20B PPP1R10 CTNNA1 PRKDC FUS KDM1A | 2.03e-05 | 809 | 200 | 16 | 32129710 | |
| Pubmed | 2.18e-05 | 10 | 200 | 3 | 23746204 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | NDUFS7 RNGTT DOCK11 TTC21A FOCAD DNAH3 MXRA5 BAZ2B HCN1 ITSN1 POLR2A ROR1 SLC26A9 SPAG9 PRKDC | 2.63e-05 | 736 | 200 | 15 | 29676528 |
| Pubmed | 2.76e-05 | 206 | 200 | 8 | 22174317 | ||
| Pubmed | TPR IFT140 SYNPO2 SPTAN1 PSMD1 EXTL3 ITSN1 NUP98 ADNP2 DUSP10 CTNNA1 PRKDC | 2.77e-05 | 486 | 200 | 12 | 20936779 | |
| Pubmed | PSMD1 RNF40 OLA1 RTF1 SUPT6H KIF2A DNM2 NAA15 NRDC PUF60 POLR2A KRR1 PRKDC FUS | 2.84e-05 | 653 | 200 | 14 | 33742100 | |
| Pubmed | 2.96e-05 | 208 | 200 | 8 | 22145905 | ||
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 2.99e-05 | 11 | 200 | 3 | 32820719 | |
| Pubmed | 3.05e-05 | 340 | 200 | 10 | 29478914 | ||
| Pubmed | TPR RNMT SPTAN1 PSMD1 NAA15 HSPA4L CCT7 SPAG9 KIF20B CTNNA1 FUS KDM1A | 3.25e-05 | 494 | 200 | 12 | 26831064 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 26061549 | ||
| Pubmed | Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia. | 3.29e-05 | 2 | 200 | 2 | 27235137 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 22762444 | ||
| Pubmed | Peripheral N- and C-terminal domains determine deactivation kinetics of HCN channels. | 3.29e-05 | 2 | 200 | 2 | 17548059 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 24799716 | ||
| Pubmed | Functional regulation of semaphorin receptors by proprotein convertases. | 3.29e-05 | 2 | 200 | 2 | 12533544 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 21402151 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 24928388 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 25978653 | ||
| Pubmed | DNA-PK, Nuclear mTOR, and the Androgen Pathway in Prostate Cancer. | 3.29e-05 | 2 | 200 | 2 | 32209447 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 34088380 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 28498454 | ||
| Pubmed | mTORC1 is a critical mediator of oncogenic Semaphorin3A signaling. | 3.29e-05 | 2 | 200 | 2 | 27246732 | |
| Pubmed | LSD1 negatively regulates autophagy through the mTOR signaling pathway in ovarian cancer cells. | 3.29e-05 | 2 | 200 | 2 | 29749504 | |
| Pubmed | Exome sequencing reveals NAA15 and PUF60 as candidate genes associated with intellectual disability. | 3.29e-05 | 2 | 200 | 2 | 28990276 | |
| Pubmed | CLCA1 Regulates Airway Mucus Production and Ion Secretion Through TMEM16A. | 3.29e-05 | 2 | 200 | 2 | 34066250 | |
| Pubmed | Structural and Biophysical Analysis of the CLCA1 VWA Domain Suggests Mode of TMEM16A Engagement. | 3.29e-05 | 2 | 200 | 2 | 31995732 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 17650673 | ||
| Pubmed | Regulation of karyopherin α1 and nuclear import by mammalian target of rapamycin. | 3.29e-05 | 2 | 200 | 2 | 22399302 | |
| Pubmed | KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancer. | 3.29e-05 | 2 | 200 | 2 | 34673129 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 28408318 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 11248054 | ||
| Pubmed | The nucleoporin Nup98 associates with the intranuclear filamentous protein network of TPR. | 3.29e-05 | 2 | 200 | 2 | 11248057 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 21364666 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 22480613 | ||
| Pubmed | Mechanosensitive EPLIN-dependent remodeling of adherens junctions regulates epithelial reshaping. | 3.29e-05 | 2 | 200 | 2 | 21844208 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 21748792 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 37219012 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 21456027 | ||
| Pubmed | Hyperpolarization-activated channels HCN1 and HCN4 mediate responses to sour stimuli. | 3.29e-05 | 2 | 200 | 2 | 11675786 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 9828141 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 16314571 | ||
| Pubmed | Two distinct mechanisms of RNA polymerase II elongation stimulation in vivo. | 3.29e-05 | 2 | 200 | 2 | 34146481 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 19135060 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 28420732 | ||
| Pubmed | Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model. | 3.29e-05 | 2 | 200 | 2 | 22465227 | |
| Pubmed | Secreted CLCA1 modulates TMEM16A to activate Ca(2+)-dependent chloride currents in human cells. | 3.29e-05 | 2 | 200 | 2 | 25781344 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 11352932 | ||
| Pubmed | 3.36e-05 | 32 | 200 | 4 | 26142281 | ||
| Interaction | FBXO22 interactions | DOCK11 GPN1 ZMYND8 CLASP2 AK9 DYSF RTF1 KIF2A HSPA4L POLR2A TOGARAM2 KMO PPP1R10 VPS13D ERLIN2 XIRP2 CTNNA1 KDM1A | 4.77e-06 | 540 | 193 | 18 | int:FBXO22 |
| Interaction | STIP1 interactions | TPR TEX2 SPTAN1 PSMD1 CLASP2 OLA1 SUPT6H KIF2A DNM2 NAA15 HSPA4L DOCK8 PUF60 POLR2A AGR2 NUP98 CCT7 SPAG9 YES1 NOMO1 MTOR CTNNA1 PRKDC FUS KDM1A | 1.22e-05 | 1006 | 193 | 25 | int:STIP1 |
| Interaction | GTF2H5 interactions | 1.97e-05 | 35 | 193 | 5 | int:GTF2H5 | |
| Interaction | DES interactions | 2.21e-05 | 158 | 193 | 9 | int:DES | |
| Interaction | BRCA1 interactions | KNTC1 TPR RNMT RNGTT SPTAN1 GPN1 PSMD1 OLA1 TRIM24 RMI1 NF1 SUPT6H C2CD6 KIF2A THOC1 NAA15 HSPA4L POLR2A CCT7 SPAG9 KIF20B GTF2F1 SLF2 MTOR CTNNA1 PRKDC FUS KDM1A | 2.33e-05 | 1249 | 193 | 28 | int:BRCA1 |
| Interaction | NUP43 interactions | MIS18BP1 ZMYND8 SRP9 GPATCH4 CCDC168 RYR2 RTF1 SUPT6H KIF2A PHIP BAZ2B NUP88 NUP98 CCT7 OSGEP SETD2 SLF2 FUS | 3.39e-05 | 625 | 193 | 18 | int:NUP43 |
| Interaction | SIRT6 interactions | MYH7 ERCC3 RNGTT DOCK11 RNF40 NF1 SUPT6H KIF2A KPNA1 HSPA4L POLR2A NUP88 NUP98 CCT7 SETD2 PRKDC FUS KDM1A | 3.61e-05 | 628 | 193 | 18 | int:SIRT6 |
| Interaction | GPHN interactions | 4.56e-05 | 134 | 193 | 8 | int:GPHN | |
| Interaction | WASHC3 interactions | 4.56e-05 | 134 | 193 | 8 | int:WASHC3 | |
| Interaction | RNGTT interactions | 5.33e-05 | 137 | 193 | 8 | int:RNGTT | |
| Interaction | RYR1 interactions | 5.48e-05 | 43 | 193 | 5 | int:RYR1 | |
| Interaction | POLR2H interactions | ERCC3 RNGTT GPN1 SOCS6 PYHIN1 SUPT6H POLR2A GTF2F1 PRKDC PRKG1 | 6.02e-05 | 223 | 193 | 10 | int:POLR2H |
| GeneFamily | Golgi associated, gamma adaptin ear containing, ARF binding proteins | 1.56e-04 | 3 | 131 | 2 | 1031 | |
| GeneFamily | Dyneins, axonemal | 2.35e-04 | 17 | 131 | 3 | 536 | |
| GeneFamily | Intraflagellar transport proteins|Tetratricopeptide repeat domain containing | 6.73e-04 | 24 | 131 | 3 | 615 | |
| GeneFamily | Nucleoporins | 1.58e-03 | 32 | 131 | 3 | 1051 | |
| GeneFamily | Sterile alpha motif domain containing|MBT domain containing | 1.81e-03 | 9 | 131 | 2 | 1263 | |
| GeneFamily | Plexins | 1.81e-03 | 9 | 131 | 2 | 683 | |
| GeneFamily | Cyclic nucleotide gated channels | 2.26e-03 | 10 | 131 | 2 | 250 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP | RNGTT ZMYND8 CLASP2 FOCAD NF1 USP51 THOC1 ADNP2 PPP1R10 VPS13D FUS | 3.51e-07 | 197 | 199 | 11 | M7403 |
| Coexpression | EPPERT_PROGENITOR | 1.10e-05 | 138 | 199 | 8 | M19232 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | TPR SYNPO2 MGAT4A TMOD2 CLASP2 EXTL3 SOCS6 SEMA3A CLCA1 FERMT2 CRISPLD1 PHIP DNM2 NIBAN1 LRRN1 ROR1 IDE IDS YES1 SLC15A2 PRKG1 | 1.01e-05 | 806 | 188 | 21 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | KNTC1 RBM44 MIS18BP1 TEX2 GNG13 SPTAN1 MGAT4A SGK3 SCML2 ETNK1 UPP1 HSPA4L NUP88 CCT7 IDE KIF20B RANBP17 MTOR CCNB2 SYT14 PRKDC | 1.08e-05 | 810 | 188 | 21 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_200 | 2.24e-05 | 171 | 188 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#1_top-relative-expression-ranked_200 | 2.33e-05 | 39 | 188 | 5 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k1_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.49e-05 | 48 | 188 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000_k4 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.77e-08 | 193 | 199 | 10 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.85e-08 | 194 | 199 | 10 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.95e-08 | 195 | 199 | 10 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | GPR155 SYNPO2 ADAM28 SVEP1 SEMA3A PDE11A MXRA5 BAZ2B DUSP10 PCDH9 | 2.48e-08 | 200 | 199 | 10 | ac8a5d71acd4d401995babd233f0d3738e8ad2a5 |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.32e-07 | 181 | 199 | 9 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.52e-07 | 184 | 199 | 9 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.52e-07 | 184 | 199 | 9 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.59e-07 | 185 | 199 | 9 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.82e-07 | 188 | 199 | 9 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.99e-07 | 190 | 199 | 9 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.99e-07 | 190 | 199 | 9 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.99e-07 | 190 | 199 | 9 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 2.08e-07 | 191 | 199 | 9 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 2.08e-07 | 191 | 199 | 9 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 2.94e-07 | 199 | 199 | 9 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-07 | 160 | 199 | 8 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-07 | 160 | 199 | 8 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.01e-06 | 170 | 199 | 8 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lhx6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.16e-06 | 120 | 199 | 7 | a4e3f9a83bc52ccc75bcd64b1be4e2c5441f6d1a | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.31e-06 | 176 | 199 | 8 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.68e-06 | 182 | 199 | 8 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.75e-06 | 183 | 199 | 8 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.90e-06 | 185 | 199 | 8 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 2.15e-06 | 188 | 199 | 8 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | PND01-Epithelial-Epithelial_Airway|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.23e-06 | 189 | 199 | 8 | 38cde34295566a4ecaf7d0a81c5a192cf17d0459 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.23e-06 | 189 | 199 | 8 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.23e-06 | 189 | 199 | 8 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | Epithelial-D_(Ciliated)|World / shred on cell class and cell subclass (v4) | 2.23e-06 | 189 | 199 | 8 | 0bf560b595c7a8450a46bc821b742b67965bd9f9 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.41e-06 | 191 | 199 | 8 | 1e21de183a9c09cfb6aad3f9b948087fb6bad061 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.41e-06 | 191 | 199 | 8 | 96483adb97c81208aa513782550acd8a08b63866 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 2.51e-06 | 192 | 199 | 8 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 2.71e-06 | 194 | 199 | 8 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.71e-06 | 194 | 199 | 8 | 69cf7c989ac355c459db13f9d4267b55adc3c174 | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.04e-06 | 197 | 199 | 8 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 3.15e-06 | 198 | 199 | 8 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 3.15e-06 | 198 | 199 | 8 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.15e-06 | 198 | 199 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 3.27e-06 | 199 | 199 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.40e-06 | 200 | 199 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Control-Epithelial_airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.23e-06 | 158 | 199 | 7 | 35aee1c3b92169e73569331022833cb44ab7e7e8 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.86e-06 | 163 | 199 | 7 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.86e-06 | 163 | 199 | 7 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.22e-06 | 164 | 199 | 7 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 172 | 199 | 7 | ee8ce9e8c9a6d3ee2be113f77743958005f4b3f0 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 172 | 199 | 7 | bd468a7ea6ec832dcf6a816a1e0c03fa0f176dad | |
| ToppCell | LPS_only-Lymphocytic_B-B_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-05 | 177 | 199 | 7 | c82332c5f656aa26513e4f7525d5d4d733019725 | |
| ToppCell | LPS_only-Lymphocytic_B|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-05 | 177 | 199 | 7 | 5ed65e08d773d157840317c72e0d43c261d438d4 | |
| ToppCell | LPS_only-Lymphocytic_B-B_cells-B-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-05 | 177 | 199 | 7 | 8a955a7ab84c434f9ad4b467246b8be3cb479406 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.63e-05 | 179 | 199 | 7 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-05 | 179 | 199 | 7 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.75e-05 | 181 | 199 | 7 | 2b9b460239d67fd480cee60820cdb306109d3567 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.75e-05 | 181 | 199 | 7 | 2a1aa4a0ec7bc367857beaff543135e4345c835b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-05 | 184 | 199 | 7 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.16e-05 | 187 | 199 | 7 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 2.23e-05 | 188 | 199 | 7 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.23e-05 | 188 | 199 | 7 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-05 | 189 | 199 | 7 | 057d7a03fdbe779122b203619a6f947f49b84d28 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-05 | 189 | 199 | 7 | b55de812043b670cbde810d7d42f45909b6d66ef | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-05 | 189 | 199 | 7 | 02c6128a9ab5818e0881dcadafdad5f08b9a67cf | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-05 | 189 | 199 | 7 | 164ea92ff6a1aa2ead1c9b8f64f99a9d65437232 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-05 | 189 | 199 | 7 | e443b02502edaefa94567a9e8af5756e8e11ff30 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-05 | 189 | 199 | 7 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-05 | 189 | 199 | 7 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-05 | 189 | 199 | 7 | 9f57a131902d23494bf389baf6e6e2d99f88b2c8 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-05 | 189 | 199 | 7 | a85099bd598a27ee64ee0664d051d89fa8d62fc9 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-05 | 189 | 199 | 7 | 4e83e49d1265ffe507fdb72924c77c4d1c73f0bd | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.39e-05 | 190 | 199 | 7 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.39e-05 | 190 | 199 | 7 | 5c012935ea5e35a2d0d08ea7dc04ffbe3c2a10ac | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.39e-05 | 190 | 199 | 7 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-05 | 190 | 199 | 7 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-05 | 190 | 199 | 7 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.47e-05 | 191 | 199 | 7 | 8688708c9183ebcb200596501dc30cc12073f151 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 192 | 199 | 7 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.55e-05 | 192 | 199 | 7 | bb7eb51bc079acacde42d8e55ba06d03eba2ea28 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 192 | 199 | 7 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.55e-05 | 192 | 199 | 7 | a50a6279371b3be682e334082637b7ab76b9a6e5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-05 | 192 | 199 | 7 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.73e-05 | 194 | 199 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.82e-05 | 195 | 199 | 7 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 2.82e-05 | 195 | 199 | 7 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.01e-05 | 197 | 199 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.11e-05 | 198 | 199 | 7 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.11e-05 | 198 | 199 | 7 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.11e-05 | 198 | 199 | 7 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.11e-05 | 198 | 199 | 7 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.11e-05 | 198 | 199 | 7 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | Transverse-(2)_B_cell-(23)_Follicular_B_cell|Transverse / shred on region, Cell_type, and subtype | 3.21e-05 | 199 | 199 | 7 | 9c49e114e17cdefc2651050fc3251e59ea251289 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.21e-05 | 199 | 199 | 7 | 6977f939ddbc47d4921f36c0a61a205259fe1284 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.21e-05 | 199 | 199 | 7 | fbd39d34636137d1b877dd8815d58f124990136b | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.21e-05 | 199 | 199 | 7 | da016849b804fbf80edbfa8f8f56c9df8bbf2d51 | |
| ToppCell | Transverse-B_cell-Follicular_B_cell|Transverse / Region, Cell class and subclass | 3.21e-05 | 199 | 199 | 7 | 1fa6e464fc929e721738e175389b85018c5e975f | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.31e-05 | 200 | 199 | 7 | 3dacd0afe69bc16bb33336ea9ea99a9cd47731d9 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-B-B_naive|COVID-19_Convalescent / Disease, condition lineage and cell class | 3.31e-05 | 200 | 199 | 7 | 5c1b51b9571681d8b792d1443d9f8926dcd55b29 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-05 | 145 | 199 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | LA-15._Ventricular_Cardiomyocyte_III|LA / Chamber and Cluster_Paper | 5.23e-05 | 147 | 199 | 6 | 8970eb6b82589f39439c61a57d999661ec8342de | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 162 | 199 | 6 | b502d6af6868425b5c919740e011330c0d3cf3b8 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.91e-05 | 165 | 199 | 6 | 953c8242a81a39ade63ac8e5b34fe58575771746 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.91e-05 | 165 | 199 | 6 | 6d315e0734079ad05336cc2c3f24d870c9105bc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.91e-05 | 165 | 199 | 6 | 84f5597b1bb75f42de9a224196bb8ac198bbe3bf | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 166 | 199 | 6 | 548d0d6c0ffd564036ddba78620734220ebb73d7 | |
| Computational | Nuclear pore complex. | 2.66e-05 | 17 | 115 | 4 | MODULE_352 | |
| Drug | ionomycin calcium salt; Down 200; 2uM; MCF7; HT_HG-U133A_EA | MIS18BP1 RNGTT SPTAN1 ZMYND8 SCML2 NF1 ITSN1 IDS WDR19 SETD2 SLC15A2 DUSP10 | 1.86e-07 | 198 | 199 | 12 | 871_DN |
| Drug | STOCK1N-35696; Up 200; 15uM; PC3; HT_HG-U133A | GGA2 RNMT RNGTT SPTAN1 MGAT4A RTF1 HSPA4L ACAD10 CARD8 HARS2 SETD2 | 1.37e-06 | 197 | 199 | 11 | 6564_UP |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.72e-05 | 49 | 193 | 5 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | ERBB4 ERCC3 SPTAN1 ARHGEF38 OLA1 DYSF SGK3 SEMA3A NF1 MACIR PLXNB1 AKAP6 ROR1 AGR2 NUP98 SETD2 MTOR FUS GGA1 | 8.72e-05 | 1074 | 193 | 19 | C0006142 |
| Disease | sick sinus syndrome (implicated_via_orthology) | 1.27e-04 | 3 | 193 | 2 | DOID:13884 (implicated_via_orthology) | |
| Disease | sensory peripheral neuropathy (implicated_via_orthology) | 2.53e-04 | 4 | 193 | 2 | DOID:2491 (implicated_via_orthology) | |
| Disease | PR interval | MYH7 DYSF RYR2 SEMA3A FERMT2 AKAP6 SLC27A6 HCN4 HCN1 YES1 DNAH11 | 4.46e-04 | 495 | 193 | 11 | EFO_0004462 |
| Disease | Paroxysmal atrial fibrillation | 5.84e-04 | 156 | 193 | 6 | C0235480 | |
| Disease | familial atrial fibrillation | 5.84e-04 | 156 | 193 | 6 | C3468561 | |
| Disease | Persistent atrial fibrillation | 5.84e-04 | 156 | 193 | 6 | C2585653 | |
| Disease | dietary heme iron intake measurement, type 2 diabetes mellitus | 6.27e-04 | 6 | 193 | 2 | EFO_0008355, MONDO_0005148 | |
| Disease | procollagen C-endopeptidase enhancer 1 measurement | 6.27e-04 | 6 | 193 | 2 | EFO_0801920 | |
| Disease | Atrial Fibrillation | 6.67e-04 | 160 | 193 | 6 | C0004238 | |
| Disease | Intellectual Disability | 7.68e-04 | 447 | 193 | 10 | C3714756 | |
| Disease | Squamous cell carcinoma of lung | 1.19e-03 | 32 | 193 | 3 | C0149782 | |
| Disease | Prostatic Cancer, Castration-Resistant | 1.49e-03 | 9 | 193 | 2 | C3658266 | |
| Disease | Prostatic Neoplasms, Castration-Resistant | 1.49e-03 | 9 | 193 | 2 | C3658267 | |
| Disease | liver cancer (is_marker_for) | 1.49e-03 | 9 | 193 | 2 | DOID:3571 (is_marker_for) | |
| Disease | skin microbiome measurement | 2.12e-03 | 39 | 193 | 3 | EFO_0801228 | |
| Disease | Jeune thoracic dystrophy | 2.25e-03 | 11 | 193 | 2 | C0265275 | |
| Disease | Profound Mental Retardation | 2.25e-03 | 139 | 193 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.25e-03 | 139 | 193 | 5 | C0025363 | |
| Disease | Mental deficiency | 2.25e-03 | 139 | 193 | 5 | C0917816 | |
| Disease | ciliopathy (implicated_via_orthology) | 2.28e-03 | 40 | 193 | 3 | DOID:0060340 (implicated_via_orthology) | |
| Disease | Cutaneous Melanoma | 2.45e-03 | 41 | 193 | 3 | C0151779 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | ERBB4 RNMT RYR2 RMI1 PDE11A AKAP6 NRAP HCN1 RANBP17 MCTP1 SYT14 PRKDC PRKG1 | 2.48e-03 | 801 | 193 | 13 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | insomnia measurement | 2.68e-03 | 443 | 193 | 9 | EFO_0007876 | |
| Disease | progression free survival, urinary bladder cancer | 2.69e-03 | 12 | 193 | 2 | EFO_0004920, MONDO_0001187 | |
| Disease | distal myopathy (implicated_via_orthology) | 2.69e-03 | 12 | 193 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | mean platelet volume | AOC1 DOCK11 TEX2 ZMYND8 SVEP1 KIF2A PHIP NIBAN1 NRDC DOCK8 POLR2A NUP88 SETD2 FADS1 OR4A15 | 3.03e-03 | 1020 | 193 | 15 | EFO_0004584 |
| Disease | Autosomal Dominant Myotubular Myopathy | 3.17e-03 | 13 | 193 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 3.17e-03 | 13 | 193 | 2 | C0175709 | |
| Disease | salicylurate measurement | 3.17e-03 | 13 | 193 | 2 | EFO_0010532 | |
| Disease | X-linked centronuclear myopathy | 3.17e-03 | 13 | 193 | 2 | C0410203 | |
| Disease | Myopathy, Centronuclear, 1 | 3.17e-03 | 13 | 193 | 2 | C4551952 | |
| Disease | phosphatidylcholine 40:7 measurement | 3.17e-03 | 13 | 193 | 2 | EFO_0021477 | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 3.17e-03 | 13 | 193 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | response to ketamine, dissociation measurement | 3.17e-03 | 13 | 193 | 2 | EFO_0009748, EFO_0009750 | |
| Disease | Congenital Structural Myopathy | 3.17e-03 | 13 | 193 | 2 | C0752282 | |
| Disease | atrial fibrillation | 3.20e-03 | 371 | 193 | 8 | EFO_0000275 | |
| Disease | RS-6-hydroxywarfarin measurement | 3.60e-03 | 155 | 193 | 5 | EFO_0803328 | |
| Disease | Malformations of Cortical Development | 3.68e-03 | 14 | 193 | 2 | C1955869 | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 3.68e-03 | 14 | 193 | 2 | C1834558 | |
| Disease | Tubular Aggregate Myopathy | 3.68e-03 | 14 | 193 | 2 | C0410207 | |
| Disease | colonic neoplasm, overall survival | 3.68e-03 | 14 | 193 | 2 | EFO_0000638, EFO_0004288 | |
| Disease | Cortical Dysplasia | 3.68e-03 | 14 | 193 | 2 | C0431380 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 4.07e-03 | 49 | 193 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | schizophrenia (biomarker_via_orthology) | 4.23e-03 | 15 | 193 | 2 | DOID:5419 (biomarker_via_orthology) | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 4.23e-03 | 15 | 193 | 2 | C3645536 | |
| Disease | asthma exacerbation measurement, response to corticosteroid | 4.56e-03 | 51 | 193 | 3 | EFO_0007614, GO_0031960 | |
| Disease | pulse pressure measurement | RNMT NEK6 TEX2 PGBD1 DYSF PLXNB2 SVEP1 STXBP2 SUPT6H FERMT2 CRISPLD1 MXRA5 ANO1 ACAD10 YES1 FADS1 KDM1A SAMD4A | 4.68e-03 | 1392 | 193 | 18 | EFO_0005763 |
| Disease | 5-oxoproline measurement | 4.81e-03 | 16 | 193 | 2 | EFO_0010988 | |
| Disease | lysosomal storage disease (implicated_via_orthology) | 4.81e-03 | 16 | 193 | 2 | DOID:3211 (implicated_via_orthology) | |
| Disease | level of Phosphatidylcholine (18:0_20:3) in blood serum | 4.81e-03 | 16 | 193 | 2 | OBA_2045093 | |
| Disease | Metastatic melanoma | 5.35e-03 | 54 | 193 | 3 | C0278883 | |
| Disease | melanoma | 5.98e-03 | 248 | 193 | 6 | C0025202 | |
| Disease | Congenital Fiber Type Disproportion | 6.08e-03 | 18 | 193 | 2 | C0546264 | |
| Disease | infant grey matter volume measurement | 6.08e-03 | 18 | 193 | 2 | EFO_0008368 | |
| Disease | aortic measurement | 6.33e-03 | 251 | 193 | 6 | EFO_0020865 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALYKSKTSNKPLMII | 61 | O95994 | |
| YLKNNILSMPEKAKK | 1221 | Q15303 | |
| YKSAPKEQRDKVQLM | 676 | O75150 | |
| AEIKHKIKMQVLLYP | 206 | Q6P093 | |
| MTINGKIAVLYLKKN | 61 | Q9UKQ2 | |
| PLSLVNQAKKETYMK | 386 | Q9UIF8 | |
| NQAKKETYMKLIVPS | 391 | Q9UIF8 | |
| QSLKKIYMQEGKPNL | 216 | Q9NXL2 | |
| KSKPNMNYDKLSRAL | 91 | Q99581 | |
| MAIVQPKYAKELKNT | 121 | Q14330 | |
| FVNMDNLIYKLLKPS | 181 | Q9Y5Z6 | |
| VKYLLMLKKQDIPDS | 731 | Q96DT5 | |
| KTMEIPKDSLQKYLK | 261 | Q6JQN1 | |
| AIYNEDIPMTKKLLL | 156 | Q6NSI1 | |
| KNTVFLIEMLLPKKY | 66 | P19801 | |
| KKAQLMQYLSLPKTP | 56 | Q6IC83 | |
| VIKLPYFNTMKPKKQ | 941 | Q14004 | |
| KKKLPMDYSNRGFQL | 796 | Q6IQ32 | |
| SLSKDQIYPMKLKGI | 816 | Q9H2T7 | |
| LSPQKVLKMKIYTEN | 316 | Q6ZP01 | |
| KALLSNIEKYKPNMI | 151 | Q9NRG1 | |
| NIEKYKPNMIKVASL | 156 | Q9NRG1 | |
| IIRFPDTVKQMNKYK | 416 | P69849 | |
| LEMKYALDPNRQIKK | 26 | Q6ZSG2 | |
| KYLEANMTQSALPKI | 281 | Q9NTK5 | |
| PQLSEPYLSKQKKLM | 201 | Q96MZ0 | |
| PYLSKQKKLMAKILE | 206 | Q96MZ0 | |
| FYQILSNKKPELLDM | 286 | P12883 | |
| MLNPLIYSLRNKDVK | 286 | Q8NGL3 | |
| NKIYVVQPKAMKIEK | 1066 | O60271 | |
| LYQEFNGLKKMNPKL | 76 | Q13231 | |
| KIQKLTDKDYMKPLL | 371 | Q9UM21 | |
| KLEKYLQKLSALPMT | 26 | Q8IYF1 | |
| LNKILKAKYPTEMII | 656 | Q5KSL6 | |
| IIRFPDTVKQMNKYK | 416 | Q5JPE7 | |
| DMKLYQTPLELKLKH | 1211 | P52948 | |
| NPLIYTLRNKDMKLA | 296 | Q8NGC9 | |
| NMKEVKKSPKQLAAY | 36 | Q9H079 | |
| HQKYKSKIMPKTLNP | 501 | Q6DN14 | |
| MAINQKKAYILVTPL | 641 | Q6P0N0 | |
| LKYQVKQPITKAEML | 921 | O60732 | |
| KIEKYNVPLNRLKMM | 186 | Q9UHB6 | |
| MDKQNIKLLDLKPYK | 276 | O60942 | |
| QTAMKLVPLKDANYR | 466 | Q86VF7 | |
| LLLSKKYKQLPHMLT | 401 | Q7Z3F1 | |
| KYKQLPHMLTTNLLI | 406 | Q7Z3F1 | |
| IKTNKKTGQPMINLY | 311 | P35637 | |
| MIEFPKKIAKNAANL | 576 | Q13976 | |
| ENLMQKKGKFDYILL | 121 | Q8IUF1 | |
| ENLMQKKGKFDYILL | 121 | Q9BRT8 | |
| IDKANYLESILMPKL | 341 | Q53TS8 | |
| SIKIIYPNDLAKKMT | 146 | Q9Y6W6 | |
| KPNLLYQKFVKMATL | 101 | Q5T3I0 | |
| KEKMLDQLYKGVPLT | 1781 | O43157 | |
| LLEQYVVAKNPKLML | 1376 | O15031 | |
| KSLDYLNLDKMIKEP | 166 | Q96GV9 | |
| NPLIYTLKNAEMKSA | 311 | Q8NGL6 | |
| MLNPLIYTVKNKAVK | 276 | A6NMZ5 | |
| MTDIPLANLKSYKQA | 1211 | Q9HC56 | |
| YQALVKVNVKLKPML | 881 | Q9HCR9 | |
| AMNYKPSPLQVKLEK | 41 | Q8IW50 | |
| LEKMFQKQKYISKPD | 196 | A6NMT0 | |
| DSLQERLYTKMNLKP | 181 | Q96Q89 | |
| IIRFPDTVKQMNKYK | 416 | Q15155 | |
| SQMIKYFKKQKRLIP | 131 | Q9HC98 | |
| LLEKSMEPSLKYINK | 46 | P55160 | |
| DHPKVKLLQESYKLM | 826 | P50748 | |
| KNIHPIYNIKSLMIK | 211 | Q13601 | |
| VMKIKLGPALKIYNS | 586 | Q8NA19 | |
| YQMLKKQGIVKSDPK | 136 | Q9UJY5 | |
| AYQMLKKQGIIKQDP | 151 | Q9UJY4 | |
| VPQMKKEVESLKYQL | 6 | Q9P2W3 | |
| PDAGQLYAMKVLKKA | 96 | Q9UK32 | |
| MKKLIRYLKLKQQSP | 686 | Q5XXA6 | |
| EQMAKRGKKLVELPY | 181 | Q9NPF4 | |
| KKYMLPLDNLKIRDV | 561 | P50570 | |
| PKQVKMVLSKLYENK | 196 | Q9P2X3 | |
| ILYKTKLPFIVVMNK | 176 | Q9HCN4 | |
| IILDPQRIKMKYLKS | 326 | Q9Y3Q4 | |
| YKGLEKALKPANMLE | 261 | Q9BXJ9 | |
| KALKPANMLERLKIY | 266 | Q9BXJ9 | |
| MKIAEANKLKLTPEY | 266 | O94905 | |
| ANKLKLTPEYLQLMK | 271 | O94905 | |
| MYVKPSAKERVSLNK | 256 | A6NCV1 | |
| VFLMLKKPNYKKLEL | 346 | O00139 | |
| LKLLKMIITQYIPKH | 501 | O60308 | |
| MIITQYIPKHKLSKL | 506 | O60308 | |
| IILDPKVIKMNYLKS | 206 | O60741 | |
| KPVIINALKAMYDLN | 256 | Q6JEL2 | |
| MELAKIKQKCPLYEA | 351 | O60341 | |
| KDLLTAAEKYPNVKM | 116 | O15229 | |
| SMATYLLEENKIKLP | 971 | Q5JSL3 | |
| LKKNYNKLKENLRPM | 2046 | Q8NF50 | |
| QYKALKPEVDKLNIM | 176 | P35221 | |
| NKYASSKLLKISMIP | 366 | O95067 | |
| KEKSTYPLLQAMLKN | 851 | Q8TD57 | |
| VPNATLLEKLLEKYM | 26 | Q9H336 | |
| SYKELMAQNQPKLSL | 141 | O43909 | |
| AMKLIKLKLQGYQLP | 81 | Q15811 | |
| EFLQYTQPMKRDIKK | 71 | Q9P0W0 | |
| LDQKKVKYPKMTDLS | 206 | Q9NWU2 | |
| MANNYKKIVLLKGLE | 1 | Q6K0P9 | |
| NLKVMPKELKLSYRS | 381 | Q9Y2G2 | |
| LQMIYKSVKLPVLKV | 621 | Q96C10 | |
| INKGLVKKYMNSLLI | 76 | O60427 | |
| SKPEKAQAMALLLYQ | 176 | Q8N2R8 | |
| PLLNEMAKKYNMKLV | 376 | O43148 | |
| KMLLPKSSALFYQKL | 486 | Q9UEF7 | |
| KKTYSKMNNPAIKRI | 36 | P14735 | |
| KTKKRILLYTMNPNK | 526 | P19447 | |
| NSDKPSLKDIKIMGY | 476 | P22304 | |
| KQKPKYVKFQMEQIS | 931 | Q8NDH2 | |
| KAKKPSISYMLNIRA | 1711 | Q8NDH2 | |
| NQYFKMKPEVTALKV | 436 | Q9HBU6 | |
| HKLLRLQLPNMKYVK | 96 | Q96AC1 | |
| LQLPNMKYVKVKVNF | 101 | Q96AC1 | |
| MFKPQALLDKAKINQ | 236 | Q96AC1 | |
| ITMPLSKNDRKKYNT | 1726 | Q8IVF4 | |
| AYEKLQILKPEAKMN | 141 | Q9UNI6 | |
| YLLKFAIQKMKQPGT | 156 | Q9ULU4 | |
| EKYPKQLIMDVKALT | 286 | Q16348 | |
| VKKMKLPKNYQLTSG | 961 | Q92736 | |
| KLYNTLKKQFPAMAL | 56 | Q96BR1 | |
| KNCGKLQTIFLKYPM | 826 | O75923 | |
| DLPSLELYVNKMKDK | 941 | Q96RY7 | |
| QKLSPIYNLVPVKMK | 471 | P02748 | |
| IYNLVPVKMKNAHLK | 476 | P02748 | |
| FILKMYETNKQPGLK | 816 | Q5VW36 | |
| QVEMPKPSHLYKKNL | 31 | P28476 | |
| KKYMQKTSSIPLNEL | 666 | Q6UXK5 | |
| KDYQQQKMEKVLSLP | 686 | Q99567 | |
| NMKTLKDPYLKGELL | 446 | Q9GZY0 | |
| KKYQIFIPMVNKVLV | 1186 | P42345 | |
| PPNYAMKKTQLLKEK | 506 | Q92541 | |
| VRVPKNTTKKYNIMA | 16 | P35269 | |
| YTLNMKLKPLVENRA | 1306 | Q5TCS8 | |
| LLNPNIAKMKEDILY | 21 | Q16831 | |
| ELCYKNPKMAIQKIS | 581 | A5PLK6 | |
| NPKMAIQKISDDYKI | 586 | A5PLK6 | |
| EKIFYLTKLNLQGKM | 361 | Q8NB59 | |
| GIKAEMLYKNNPKLL | 436 | P49590 | |
| PEQQEALQKAKKYAM | 61 | Q9UHX1 | |
| MDPQKVLLAKQKYLK | 556 | Q7LBE3 | |
| LKQSLPSYDLQKVMA | 691 | Q6ZUX3 | |
| FNPAKELMAKLQKLQ | 301 | Q8IZP6 | |
| MKQSKKDPLQYQKFL | 561 | Q9H9A7 | |
| LKSYKNKSLNPDEMR | 11 | P52294 | |
| LNPLMYSLRNKDVKK | 336 | Q8NGC0 | |
| NPLIYSLRNKDMLKA | 286 | Q8NG95 | |
| TIPLKKKLESYLDLM | 231 | Q96CS2 | |
| LNKDLKMPKVQYKSN | 791 | Q99460 | |
| LNVYSKNMDKIRLPS | 366 | Q9H1N7 | |
| EMQPKKYHNPKIALL | 226 | Q99832 | |
| AEHKLKTMYKSQLLP | 271 | Q6UW49 | |
| SMYAELKSQKIKIPS | 1131 | Q8NEZ3 | |
| KNDMLQFKIYDPQKK | 1026 | P14410 | |
| RYLVQMKPSDLLKKM | 1046 | Q8IX21 | |
| KNNVPRLKLSYKEML | 26 | Q14563 | |
| VKKLPKHYANQLMLS | 91 | O95149 | |
| IKQMNKNFLLYAPLE | 526 | Q96JS3 | |
| LTNKMAPALRKVYDQ | 126 | O75251 | |
| PMLNSLIYSLKNKEV | 281 | Q8NH09 | |
| NKLKRTLNKDPMYSF | 951 | Q4LDE5 | |
| SYLQGSKLKLPMIMK | 1471 | Q13023 | |
| QQYKILDVMLKGLFK | 61 | Q9H6E4 | |
| IPKVQEKTDLYQKQM | 91 | Q8NEL0 | |
| KNTKMAYLQIPGIAK | 546 | A8K7I4 | |
| QLTGSKMKLLNLYIK | 1261 | O75122 | |
| SKEKNKMEILYILVP | 396 | Q01973 | |
| LYVQMAKELKNKLLA | 721 | Q7KZ85 | |
| KTPLMIAEEKYRQQK | 2366 | A4UGR9 | |
| YKIIKNPMDLSTIKK | 936 | O15164 | |
| YQESTKQLTMKKLPI | 576 | Q70EK9 | |
| MVKTLEYIKKQSKQP | 931 | Q7Z3J2 | |
| TKILSKKYRELPEQM | 131 | P0CB47 | |
| VYTNAKKQMLISLAP | 676 | Q9Y5T5 | |
| KKPLNALDVMKHQPY | 956 | Q9UMS6 | |
| IVNSKNYLIGKIKAM | 316 | Q9BZQ8 | |
| EMARKNKIYSINPKK | 976 | Q8WWQ0 | |
| EQINLYLKMEKKPNK | 681 | Q9UMS5 | |
| MKLEAIDKKNPYLIC | 176 | Q9UQR0 | |
| AKIVKPGMKLTELYN | 386 | P12270 | |
| DKLQELKKYGQPIQM | 676 | O95757 | |
| YEALKEPMVARKQKL | 766 | Q13813 | |
| KVYMHLPQTDNKKKI | 1306 | P24928 | |
| LSQILKKMPQYQKEL | 326 | Q15833 | |
| KPVYKNLQLFMENKD | 381 | Q969P6 | |
| QATKLILNYPKAKME | 786 | P21359 | |
| FQYLKMLQKLGPEKR | 526 | O43847 | |
| QYQKALDMLLSAPKD | 466 | Q9P0W8 | |
| KNSLEKKPKSYMVGL | 166 | Q96LQ0 | |
| YVFLKQIPKARMQLK | 1171 | Q8NDW8 | |
| KLKHLPEKYMMNSVL | 376 | Q15561 | |
| VMNKELKYCKNPEDL | 2516 | Q9BYW2 | |
| PLKTKVLDMSQNYIA | 51 | Q9Y2C9 | |
| NLMKALKMSPYKDIL | 1401 | P78527 | |
| AYPALVVEKMLKALK | 3441 | P78527 | |
| LAKTPVNKKNIEKMY | 3596 | P78527 | |
| KLYLADPMKARVVLK | 16 | P49458 | |
| AAVQKAIPMYKIATK | 146 | P36543 | |
| KPKLEQLKTVLEMYG | 456 | O43314 | |
| MNKPLKAKEAYLKAL | 576 | Q6ZXV5 | |
| KISEPLYFMDNLKKS | 586 | Q9Y2P4 | |
| MKLSKIKLPYFMNEL | 851 | Q8IWB9 | |
| LYKQMKQLKNPLEIV | 161 | P49788 | |
| KMDILINTQKNYKLP | 101 | Q5T0J7 | |
| LKQPDYSDKIKQMLV | 601 | Q96QC0 | |
| MALPFQKELEKYKNI | 1 | Q9NZR1 | |
| KPGNLDAKVEYMKLL | 91 | Q9UPU9 | |
| DAKVEYMKLLPKILA | 96 | Q9UPU9 | |
| LIQKLPLPNKMKDYL | 516 | O14544 | |
| KSLPEYLENMVIKLA | 516 | Q96FV9 | |
| DPYKRAQLKAILSQM | 61 | A6NP61 | |
| NNTLSKPTRYQKIMK | 771 | Q9HCX4 | |
| KYLKLPQLVDMAAQI | 366 | P07947 | |
| LLEKNPDSKYKNLMV | 1676 | Q5THJ4 | |
| IKKPMDVYKIHLNQT | 336 | Q9NR99 |